Compliance Blog
Managing Compliance Remotely – Responding to COVID-19
On Monday, April 13, 2020, I will be joining an elite group of fellow panelists to discuss the opportunities and challenges of managing a pharmaceutical or medical device compliance function...
API Manufacturers Beware – New Washington Opioid Lawsuit Targets J&J’s API Business
The epidemic of opioid lawsuits continues to pick-up steam. The latest case is the State of Washington’s latest suit against Johnson & Johnson (“J&J”). It, in part, targets J&J's...
Policy & Medicine Compliance Update Begins Its Sixth Year
Since 2019 was a landmark year for compliance, we felt it appropriate as we begin our sixth publication year to feature a retrospective look at 2019’s Top 10 Compliance Milestones, and what they...
HAPPY HOLIDAY WISHES FROM THE WHITELAW COMPLIANCE GROUP
Roy Snell Health Care Regulatory & Compliance Writing Competition
Mitchell Hamline School of Law is pleased to announce the first annual Roy Snell Health Care Regulatory & Compliance Writing Competition. This competition recognizes students for innovative,...
The Critical Need to Integrate Effective Compliance Controls in the Ongoing Opioid Settlements
The current U.S. opioid epidemic has been branded as “the worst drug crisis in America’s history” and a “man-made plague.” According to the Centers for Disease Control and Prevention (“CDC”), the...
Pharmaceutical & Medical Device Compliance Congress Turns 20
It is hard to believe that this is the 20th Anniversary of the Pharma Compliance Congress. Since the Pharmaceutical Compliance Forum (“PCF”) sponsored the first Congress in 2000, the profession has...
Latest Issue of the Policy & Medicine Compliance Update
For August, our focus is once again on compliance in research, and we start with a look at the world of collaborative research. Maureen Lloyd and her fellow co-authors take an in-depth look at the...
The Time for Effective Compliance Is NOW
Recently, the Justice Department targeted three companies in the pharmaceutical and medical device industry (Rochester Drug Co-Operative, Indivior, and Life Spine) as it aims to stamp out health...